Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis-Reference-Cited by-同舟云学术

Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis

Published:2017-04 Issue:14 Volume:96 Page:e6556
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Siqi,Wang Yuqiong,Xu Jinming,Chen Yuxin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case–control study;Simonsen;Drug Saf,2013

2. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma;Henriksson;J Clin Invest,1989

3. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.;Lancet,1973

4. Gall stones and oral contraceptives;Howat;J Int Med Res,1975

5. Non-contraceptive estrogen use and the risk of gallstone disease in women;Kakar;Am J Public Health,1988

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Epidemiology of Gallstones in the 21st Century: A Systematic Review and Meta-Analysis;Clinical Gastroenterology and Hepatology;2024-08

2. Approaching Digestive Health Care in Transgender and Gender-Diverse Communities;Gastroenterology;2024-03

3. Approaching Digestive Health Care in Transgender and Gender-Diverse Communities;Clinical Gastroenterology and Hepatology;2024-03

4. Risks of digestive diseases in long COVID: evidence from a population-based cohort study;BMC Medicine;2024-01-10

5. Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study;Scientific Reports;2024-01-02